intermediatetardive dyskinesiaAIMSantipsychotic side effectsmovement disordersrating scaleshaloperidol
A 58-year-old female with chronic schizophrenia has been maintained on haloperidol for 12 years. During a routine visit, the PMHNP observes repetitive lip-smacking and tongue protrusion movements. The patient is unaware of these movements. The PMHNP plans to conduct a systematic side effect assessment. Which approach reflects the most appropriate use of a standardized rating scale for this presentation?